R. Ganugula

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The current methods for targeted drug delivery utilize ligands that must out-compete endogenous ligands in order to bind to the active site facilitating the transport. To address this limitation, we present a non-competitive active transport strategy to overcome intestinal barriers in the form of tunable nanosystems (NS) for transferrin receptor (TfR)(More)
  • 1